Mednax (MD) PT Lowered to $48 at Mizuho Securities
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall Street dips as higher yields, rising oil prices mark shaky start to SeptemberÂ
- Oil prices jump 4% as fresh US-Iran fighting stokes supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- Fed’s Barr backs rate hike if inflation fails to cool, September odds hit 66%
- The Warsh pivot markets didn't expect
Mednax (MD) PT Lowered to $46 at Jefferies; Reiterates Hold
July 31, 2017 8:19 AM EDTJefferies lowered its price target on Mednax (NYSE: MD) to $46.00 (from $53.00) while maintaining a Hold rating Following the company's 2Q.
On its Q2 earnings call, MD noted that given operating challenges in the anesthesia sector and acquisition valuations,... More
MEDNAX (MD) Misses Q2 EPS by 19c, Miss on Revenues; Q3 EPS Guidance Below Consensus
July 28, 2017 6:06 AM EDTMEDNAX (NYSE: MD) reported Q2 EPS of $0.69, $0.19 worse than the analyst estimate of $0.88. Revenue for the quarter came in at $843 million versus the consensus estimate of $848.82 million.
For the 2017 second quarter, MEDNAX reported the following results:
Net revenue of $843 million;Net income of $64 million; andEBITDA of $148 million.2017 Third... More
